Literature DB >> 20959854

Multiple sites of vasopressin synthesis in the injured brain.

Joanna Szmydynger-Chodobska1, Brian J Zink, Adam Chodobski.   

Abstract

Previous studies have indicated that the primary targets for vasopressin actions on the injured brain are the cerebrovascular endothelium and astrocytes, and that vasopressin amplifies the posttraumatic production of proinflammatory mediators. Here, the controlled cortical impact model of traumatic brain injury in rats was used to identify the sources of vasopressin in the injured brain. Injury increased vasopressin synthesis in the hypothalamus and cerebral cortex adjacent to the posttraumatic lesion. In the cortex, vasopressin was predominantly produced by activated microglia/macrophages, and, to a lesser extent, by the cerebrovascular endothelium. These data further support the pathophysiological role of vasopressin in brain injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959854      PMCID: PMC3049471          DOI: 10.1038/jcbfm.2010.188

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

1.  Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury.

Authors:  Joanna Szmydynger-Chodobska; Leora M Fox; Kirsten M Lynch; Brian J Zink; Adam Chodobski
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

2.  Electron-immunocytochemistry of peptides in endothelial cells of rabbit cerebral vessels following perfusion with a perfluorocarbon emulsion.

Authors:  A Loesch; F R Domer; B Alexander; G Burnstock
Journal:  Brain Res       Date:  1993-05-21       Impact factor: 3.252

3.  Kinetics of arginine-vasopressin uptake at the blood-brain barrier.

Authors:  B V Zlokovic; S Hyman; J G McComb; M N Lipovac; G Tang; H Davson
Journal:  Biochim Biophys Acta       Date:  1990-06-27

4.  Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat.

Authors:  R M Buijs; D F Swaab; J Dogterom; F W van Leeuwen
Journal:  Cell Tissue Res       Date:  1978-01-31       Impact factor: 5.249

5.  The presence of arginine vasopressin and its mRNA in rat choroid plexus epithelium.

Authors:  A Chodobski; Y P Loh; S Corsetti; J Szmydynger-Chodobska; C E Johanson; Y P Lim; P R Monfils
Journal:  Brain Res Mol Brain Res       Date:  1997-08

6.  Morphology of vasopressin and oxytocin neurones and their central and vascular projections.

Authors:  M V Sofroniew
Journal:  Prog Brain Res       Date:  1983       Impact factor: 2.453

7.  Evaluation of the secretory pattern of plasma arginine vasopressin in stroke patients.

Authors:  T Barreca; C Gandolfo; G Corsini; M Del Sette; A Cataldi; E Rolandi; R Franceschini
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

8.  Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.

Authors:  P S Sørensen; A Gjerris; M Hammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

9.  Increased expression of vasopressin v1a receptors after traumatic brain injury.

Authors:  Joanna Szmydynger-Chodobska; Insung Chung; Ewa Koźniewska; Bao Tran; Frederick J Harrington; John A Duncan; Adam Chodobski
Journal:  J Neurotrauma       Date:  2004-08       Impact factor: 5.269

10.  Kinetics of circulating vasopressin uptake by choroid plexus.

Authors:  B V Zlokovic; M B Segal; J G McComb; S Hyman; M H Weiss; H Davson
Journal:  Am J Physiol       Date:  1991-02
View more
  12 in total

1.  Heightening of the stress response during the first weeks after a mild traumatic brain injury.

Authors:  G S Griesbach; D A Hovda; D L Tio; A N Taylor
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

2.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

3.  Understanding the renal response to brain injury.

Authors:  Matthieu Legrand; Romain Sonneville
Journal:  Intensive Care Med       Date:  2019-07-11       Impact factor: 17.440

Review 4.  Emerging therapeutic targets for cerebral edema.

Authors:  Ruchira M Jha; Sudhanshu P Raikwar; Sandra Mihaljevic; Amanda M Casabella; Joshua S Catapano; Anupama Rani; Shashvat Desai; Volodymyr Gerzanich; J Marc Simard
Journal:  Expert Opin Ther Targets       Date:  2022-01-02       Impact factor: 6.797

5.  Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.

Authors:  Christina R Marmarou; Xiuyin Liang; Naqeeb H Abidi; Shanaz Parveen; Keisuke Taya; Scott C Henderson; Harold F Young; Aristotelis S Filippidis; Clive M Baumgarten
Journal:  Brain Res       Date:  2014-06-13       Impact factor: 3.252

6.  Vasopressin V1a Receptors Regulate Cerebral Aquaporin 1 after Traumatic Brain Injury.

Authors:  Katrin Rauen; Viorela Pop; Raimund Trabold; Jerome Badaut; Nikolaus Plesnila
Journal:  J Neurotrauma       Date:  2019-12-04       Impact factor: 5.269

Review 7.  Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response.

Authors:  Evan A Bordt; Caroline J Smith; Tyler G Demarest; Staci D Bilbo; Marcy A Kingsbury
Journal:  Neurotox Res       Date:  2018-09-27       Impact factor: 3.911

8.  Early Life Stress Preceding Mild Pediatric Traumatic Brain Injury Increases Neuroinflammation but Does Not Exacerbate Impairment of Cognitive Flexibility during Adolescence.

Authors:  Naima Lajud; Angélica Roque; Jeffrey P Cheng; Corina O Bondi; Anthony E Kline
Journal:  J Neurotrauma       Date:  2020-11-06       Impact factor: 5.269

9.  The Modulatory Effect of Ischemia and Reperfusion on Arginine Vasopressin-Induced Arterial Reactions.

Authors:  Katarzyna Szadujkis-Szadurska; Bartosz Malinowski; Małgorzata Piotrowska; Grzegorz Grześk; Michał Wiciński; Marta Gajdus
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

10.  Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.

Authors:  Jared J Grantham; Arlene B Chapman; Jaime Blais; Frank S Czerwiec; Olivier Devuyst; Ron T Gansevoort; Eiji Higashihara; Holly Krasa; Wen Zhou; John Ouyang; Ronald D Perrone; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2017-06-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.